On July 8, 2021, the Board of Directors of Parallax Health Sciences Inc. approved the following changes to its executive leadership. Effective July 7, 2021, Mr. Paul R. Arena resigned as Chairman of the Board of Directors, and as a director of the Company. His resignation did not involve any disagreement with the Company. Effective July 8, 2021, Dr. Jorn Gorlach was unanimously elected as a member of the Board. Dr. Gorlach formerly served as a member of the Company’s Board between November 1, 2012, until his resignation on July 26, 2017. Dr. Gorlach has over twenty-five years of experience in the bio-medical field. In 2001, Dr. Gorlach co-founded AAvantgarde, a management consulting firm focused on the development and support of start-up companies. Since the inception of AAvantgarde in 2001, Dr. Gorlach has also served as one of its directors. As a co-founder and director of AAvantgarde, Dr. Gorlach is responsible for management consulting, licensing, and general operations. Since 2006, Dr. Gorlach has also served as a co-founder and director of Montecito BioSciences Ltd., a diagnostics and testing company with proprietary technology for point-of-care diagnostics, testing, and data communication.